Focus:
Research Reports
-
29 October 2019
Global allergic rhinitis immunotherapy market set to reach $1.14bn by 2028, driven by growth in the US and Japan, says GlobalData
Allergic rhinitis (AR) is a common disease that causes sufferers to react adversely to otherwise innocuous inhaled substances. The most prevalent symptoms of the disease include rhinorrhea, nasal congestion, sneezing,...
-
29 October 2019
Global post-traumatic stress disorder market set to reach US$1.2 billion by 2028, says GlobalData
Post-traumatic stress disorder (PTSD) is a psychiatric disorder that occurs in those who have experienced or witnessed a traumatic event. This disorder commonly affects soldiers after deployment, and can also...
-
29 October 2019
Precision medicine set to make steady headway in Japan, says GlobalData
A biomarker is a molecular characteristic that can tell a physician about a patient’s disease status and provides an indication of how a patient may respond to treatment. An example...
-
29 October 2019
Undiagnosed cases contribute substantially to the burden of allergic rhinitis, says GlobalData
Allergic rhinitis (AR) is a chronic inflammatory disease that affects the nasal mucosa. The condition is caused by immunoglobin E (IgE) – mediated early-phase and late-phase hypersensitivity responses. Common symptoms...
-
20 September 2019
Diagnosed ovarian cancer cases set to reach 66,000 across seven major markets in 2028, says GlobalData
Ovarian cancer is the most lethal gynaecologic cancer and is currently a leading cause of mortality across the world. The disease is characterised by excessive cell growth in the ovaries,...
-
20 September 2019
Total prevalent cases of female infertility to decline to 13.4 million in 2028, says GlobalData
Infertility describes a difficulty in becoming pregnant after trying for a period of one year or more. Impaired feduncity is a similar issue however also includes problems becoming pregnant and...
-
20 September 2019
Nursing home population in the 7MM, a high risk group for RSV infections, set to grow by 24% to 6.2m people by 2028, says GlobalData
Human Respiratory Syncytial Virus (RSV) is an enveloped, single-stranded, negative-sense RNA orthopneumovirus which belongs to the bigger family of Paramyxoviridae. This disease has only been public knowledge since 1956, when...
-
20 September 2019
Alopecia Areata market set to be worth $1.7bn by 2028 driven by the launch of JAK inhibitors, says GlobalData
Alopecia Areata (AA) is a non-scarring form of alopecia which is also the second most common in the world. There are no clear reasons or causes for the development of...
-
20 September 2019
Global spinal muscular atrophy market set to reach US$6.6bn in 2028, says GlobalData
Spinal muscular atrophy (SMA) is a group of neurological disorders that cause a loss in muscle movement due to depleting motor neurons and progressive muscle wasting. The disease can be...
-
20 September 2019
Global Hemophilia A and B market set to reach $9.3bn by 2028, says GlobalData
Hemophilia A and B are both rare, genetic disorders which are X chromosome linked and cause a deficiency in blood clotting factors VIII (FVIII) and IX (FIX). Hemophilia can be...